Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 022505
Company: THERATECHNOLOGIES
Company: THERATECHNOLOGIES
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
EGRIFTA | TESAMORELIN ACETATE | EQ 1MG BASE/VIAL | POWDER;SUBCUTANEOUS | Prescription | None | No | No |
EGRIFTA | TESAMORELIN ACETATE | EQ 2MG BASE/VIAL | POWDER;SUBCUTANEOUS | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/10/2010 | ORIG-1 | Approval | N/A |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022505s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022505s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022505Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/27/2024 | SUPPL-18 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022505s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/022505Orig1s018ltr.pdf | |
07/05/2019 | SUPPL-13 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022505Orig1s012, s013ltr.pdf | |
07/05/2019 | SUPPL-12 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022505Orig1s012, s013ltr.pdf | |
01/18/2019 | SUPPL-11 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022505Orig1s011ltr.pdf | |
SUPPL-10 | Supplement |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505Orig1s010lbl.pdf | ||
06/08/2015 | SUPPL-7 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022505s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022505Orig1s007ltr.pdf | |
02/09/2015 | SUPPL-6 | Supplement |
Label is not available on this site. |
||
12/15/2014 | SUPPL-5 | Supplement |
Label is not available on this site. |
||
01/07/2013 | SUPPL-4 | Supplement |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022505s004lbl.pdf | |
11/29/2011 | SUPPL-3 | Supplement |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022505s001s003lbl.pdf | |
11/29/2011 | SUPPL-1 | Supplement |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022505s001s003lbl.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
02/27/2024 | SUPPL-18 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022505s018lbl.pdf | |
02/27/2024 | SUPPL-18 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022505s018lbl.pdf | |
02/27/2024 | SUPPL-18 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022505s018lbl.pdf | |
07/05/2019 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
07/05/2019 | SUPPL-13 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
07/05/2019 | SUPPL-13 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
07/05/2019 | SUPPL-12 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
07/05/2019 | SUPPL-12 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
07/05/2019 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
07/05/2019 | SUPPL-12 | Labeling-Proprietary Name Change | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s012s013lbl.pdf | |
01/18/2019 | SUPPL-11 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505s011lbl.pdf | |
06/08/2015 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022505s007lbl.pdf | |
01/07/2013 | SUPPL-4 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022505s004lbl.pdf | |
11/29/2011 | SUPPL-3 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022505s001s003lbl.pdf | |
11/29/2011 | SUPPL-1 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022505s001s003lbl.pdf |
11/10/2010 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022505s000lbl.pdf | |
SUPPL-10 | Manufacturing (CMC)-Formulation | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505Orig1s010lbl.pdf |